JANX logo

Janux Therapeutics (JANX) Company Overview

Profile

Full Name:

Janux Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 11, 2021

Indexes:

Not included

Description:

Janux Therapeutics is a biotechnology company focused on developing innovative cancer therapies. They create unique treatments that target specific cancer cells while sparing healthy ones, aiming to improve patient outcomes and reduce side effects. Their approach combines advanced technology with a deep understanding of cancer biology.

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 10, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 3, 25 HC Wainwright & Co.
Buy
Feb 28, 25 Scotiabank
Sector Perform
Dec 11, 24 Cantor Fitzgerald
Overweight
Dec 4, 24 Scotiabank
Sector Perform
Dec 3, 24 Stifel
Buy
Dec 3, 24 Leerink Partners
Outperform
Dec 3, 24 HC Wainwright & Co.
Buy
Nov 22, 24 Leerink Partners
Outperform
Nov 7, 24 HC Wainwright & Co.
Buy
Nov 7, 24 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Janux Therapeutics?
  • Does Janux Therapeutics pay dividends?
  • What sector is Janux Therapeutics in?
  • What industry is Janux Therapeutics in?
  • What country is Janux Therapeutics based in?
  • When did Janux Therapeutics go public?
  • Is Janux Therapeutics in the S&P 500?
  • Is Janux Therapeutics in the NASDAQ 100?
  • Is Janux Therapeutics in the Dow Jones?
  • When was Janux Therapeutics's last earnings report?
  • When does Janux Therapeutics report earnings?
  • Should I buy Janux Therapeutics stock now?

What is the ticker symbol for Janux Therapeutics?

The ticker symbol for Janux Therapeutics is NASDAQ:JANX

Does Janux Therapeutics pay dividends?

No, Janux Therapeutics does not pay dividends

What sector is Janux Therapeutics in?

Janux Therapeutics is in the Healthcare sector

What industry is Janux Therapeutics in?

Janux Therapeutics is in the Biotechnology industry

What country is Janux Therapeutics based in?

Janux Therapeutics is headquartered in United States

When did Janux Therapeutics go public?

Janux Therapeutics's initial public offering (IPO) was on June 11, 2021

Is Janux Therapeutics in the S&P 500?

No, Janux Therapeutics is not included in the S&P 500 index

Is Janux Therapeutics in the NASDAQ 100?

No, Janux Therapeutics is not included in the NASDAQ 100 index

Is Janux Therapeutics in the Dow Jones?

No, Janux Therapeutics is not included in the Dow Jones index

When was Janux Therapeutics's last earnings report?

Janux Therapeutics's most recent earnings report was on Nov 6, 2024

When does Janux Therapeutics report earnings?

The next expected earnings date for Janux Therapeutics is May 8, 2025

Should I buy Janux Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions